The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling studyNora Schmit, Peter Winskill, Aboubakary Sourabié et al.|The Lancet Infectious Diseases|2024Cited by 48
Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort studyHamtandi Magloire Natama, Anna Rosanas‐Urgell, Innocent Valéa et al.|Malaria Journal|2018Cited by 47
Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of lifeHamtandi Magloire Natama, Anna Rosanas‐Urgell, Innocent Valéa et al.|BMC Medicine|2018Cited by 38
Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testingHamtandi Magloire Natama, Anna Rosanas‐Urgell, Elisa Serra‐Casas et al.|Scientific Reports|2017Cited by 36
Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina FasoHamtandi Magloire Natama, Carlota Dobaño, Innocent Valéa et al.|Infection and Immunity|2023Cited by 12